Patent Yard Sign in
Canadian application, no grantCanada

Imidazonaphthyridines

CA 2349476 A1 · Owner: Byk Gulden Lomberg Chemische Fabrik Gmbh · Inventors: Senn-Bilfinger, Jorg

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds of formula (I), in which the substituents are as defined in the description are suitable for preventing and treating gastrointestinal disorders.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 29, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 29, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 29, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 29, 1999
GrantedNo grant recorded
Term endedOctober 29, 2019
Patent numberCA 2349476 A1
Classification (IPC)C07D471/14 +1 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedOct 29, 1999Term endedOct 29, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.